Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic.

ABSTRACT:

Background

Cancer diagnostics and surgery have been disrupted by the response of health care services to the coronavirus disease 2019 (COVID-19) pandemic. Progression of cancers during delay will impact on patients' long-term survival.

Patients and methods

We generated per-day hazard ratios of cancer progression from observational studies and applied these to age-specific, stage-specific cancer survival for England 2013-2017. We modelled per-patient delay of 3 and 6 months and periods of disruption of 1 and 2 years. Using health care resource costing, we contextualise attributable lives saved and life-years gained (LYGs) from cancer surgery to equivalent volumes of COVID-19 hospitalisations.

Results

Per year, 94 912 resections for major cancers result in 80 406 long-t

SUBMITTER: Sud A 

PROVIDER: S-EPMC7237184 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature